Rapid site specific needle delivery adjustable vessel occlusion for control of junctional and non-compressible hemorrhage.
Ended Definitive Contract Awarded Last action
- Contract number
- H9242922C0002
- Awardee
-
Amsel Medical Corporation UEI UUM9WLJWJQ24
- Awarding agency
-
US Special Operations Command
Department of Defense
- Obligated
- $1,492,721
Award facts
- Contract value 100% obligated
- $1,492,720.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Air Force Research Laboratory Air Force Materiel Command, Department of Defense
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 645 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Cambridge, MA 02139, USA
- Research
- SBIR Program Phase II Action
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $1,492,721 |
About this award
The Department of the Air Force Materiel Command Research Laboratory awarded a definitive contract valued at one million four hundred ninety-two thousand seven hundred twenty dollars and ninety-two cents ($1,492,720.92) to Amsel Medical Corporation. The firm fixed price contract is for the period of July 20, 2022 through April 20, 2024 and will be performed in Cambridge, Massachusetts. The purpose of the contract is to provide Rapid Site Specific Needle Delivery Adjustable Vessel Oclusion for Control of Junctional and Non-Compressible Hemorrhage under the Small Business Innovation Research Program Phase II Action. The contract has been set aside as a total small business procurement.
Quick answers
Who was awarded contract H9242922C0002?
H9242922C0002 was awarded to Amsel Medical Corporation by US Special Operations Command (Department of Defense) on July 20, 2022.
How much is contract H9242922C0002 worth?
The government has obligated $1,492,721 on H9242922C0002.
Which agency awarded contract H9242922C0002?
US Special Operations Command (Department of Defense) awarded H9242922C0002, with funding from Air Force Research Laboratory (Air Force Materiel Command).
Was contract H9242922C0002 competed?
The extent of competition for H9242922C0002 was full and open competition after exclusion of sources. The government received 645 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award